Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prime Medicine, Inc.

1.68
-0.0600-3.45%
Post-market: 1.710.0300+1.79%19:05 EDT
Volume:1.05M
Turnover:1.83M
Market Cap:214.47M
PE:-1.02
High:1.83
Open:1.77
Low:1.67
Close:1.74
Loading ...
May 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 10, 2023

Major Issues Report

8-K/A [Amend] - Current report
Mar 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2023

Major Issues Report

8-K - Current report
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 24, 2022

Major Issues Report

8-K - Current report
Oct 20, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Oct 19, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Oct 17, 2022

Correspondence

CORRESP [Cover] - Correspondence
Oct 17, 2022

Correspondence

CORRESP [Cover] - Correspondence